Education
About Us
Working with TipRanks
Follow Us
Marks Gilbert Lynn Insider Profile
4 Followers
Marks Gilbert Lynn, Director at AN2 Therapeutics, Inc., holds 31.80K shares in AN2 Therapeutics, Inc. (Ticker: ANTX).
Marks Gilbert Lynn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Marks Gilbert Lynn's holdings
Insider Roles
Director
Roles that Marks Gilbert Lynn holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Marks Gilbert Lynn
Marks Gilbert Lynn's Trading History
List of latest transactions for each holding click on a transaction to see Marks Gilbert Lynn's performance on stock
You May Also Like
Marks Gilbert Lynn insider profile FAQ
What is the percentage of profitable transactions made by Marks Gilbert Lynn?
The percentage of profitable transactions made by Marks Gilbert Lynn is ―.
What is the average return per transaction made by Marks Gilbert Lynn?
The average return per transaction made by Marks Gilbert Lynn is ―.
What stocks does Marks Gilbert Lynn hold?
Marks Gilbert Lynn holds: ANTX stocks.
What was Marks Gilbert Lynn’s latest transaction?
Marks Gilbert Lynn latest transaction was an Uninformative Buy of ―.
What was Marks Gilbert Lynn's most profitable transaction?
Marks Gilbert Lynn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Marks Gilbert Lynn's role in AN2 Therapeutics, Inc.?
Marks Gilbert Lynn's role in AN2 Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.